SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001493152-20-022373
Filing Date
2020-11-24
Accepted
2020-11-24 07:51:45
Documents
2

Document Format Files

Seq Description Document Type Size
1 form424b3.htm 424B3 1102358
2 img_001.jpg GRAPHIC 35618
  Complete submission text file 0001493152-20-022373.txt   1152624
Mailing Address 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452
Business Address 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452 (201) 444-4947
RespireRx Pharmaceuticals Inc. (Filer) CIK: 0000849636 (see all company filings)

IRS No.: 330303583 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-249469 | Film No.: 201339944
SIC: 2834 Pharmaceutical Preparations